ESC Professional Premium Access

Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation

Congress Presentation

About the speaker

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)
4 presentations
0 follower

8 more presentations in this session

Incidence of silent brain injury in pacemaker implanted patients with atrial high-speed episodes (AHRE)

Speaker: Doctor M. Uyanik (Samsun, TR)

Thumbnail

Altered fibrin clot properties and elevated von Willebrand Factors level are associated with progression to permanent atrial fibrillation during follow-up: a cohort study

Speaker: Doctor K. Nowak (Krakow, PL)

Thumbnail

The triglyceride-glucose index is a marker of thromboembolic events in atrial fibrillation patient under oral anticoagulation therapy

Speaker: Doctor J. Rivera-Caravaca (Murcia, ES)

Thumbnail

Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF

Speaker: Doctor T. Chao (Taipei, TW)

Thumbnail

Resolution of silent left atrial thrombi and clinical outcomes in patients with atrial fibrillation: insight from the LAT trial

Speaker: Doctor N. Tanaka (Osaka, JP)

Thumbnail

Access the full session

Risk assessment and prevention of brain infarction in atrial fibrillation

Speakers: Associate Professor Z. Hijazi, Doctor M. Uyanik, Doctor K. Nowak, Doctor J. Rivera-Caravaca, Doctor T. Chao...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations